Patents by Inventor Scott D. Quinnell

Scott D. Quinnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240058612
    Abstract: An external ambulatory medical system configured to be worn by a patient and release a fluid to the patient's skin before providing therapy is provided. The medical system includes a garment configured to be worn about the patient's torso, a medical device controller configured to receive cardiac signals of the patient, and a plurality of therapy electrodes configured to be operably connected to the medical device controller and disposed in the garment. Each of the plurality of therapy electrodes includes a pressure source configured to provide a pressurized fluid to facilitate conductive gel deployment for the medical system. The pressure source includes a reservoir containing the pressurized fluid and at least one release mechanism configured to cause a release of the pressurized fluid from the reservoir to an exit port of the pressure source when the medical system is preparing to deliver a therapeutic shock to the patient.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 22, 2024
    Inventors: Robert J. Hulings, Scott D. Quinnell, Ronald A. Seman, Dale Ballard
  • Patent number: 11819694
    Abstract: A therapy electrode apparatus for dispensing conductive gel to skin of a patient wearing a wearable defibrillator includes a therapy electrode, at least one reservoir comprising the conductive gel, and a gel deployment device comprising at least two reactive chemicals. The at least one reservoir is configured to release the conductive gel between the therapy electrode and a patient's skin prior to a delivery of one or more therapeutic shocks. The gel deployment device configured to, on receiving a treatment signal from a controller of the wearable defibrillator operably connected to the gel deployment device, cause the at least two reactive chemicals to come into contact to produce a pressurized fluid to release the conductive gel from the at least one reservoir between the therapy electrode and the patient's skin.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: November 21, 2023
    Assignee: ZOLL Medical Corporation
    Inventors: Robert J Hulings, Scott D Quinnell, Ronald A Seman, Dale Ballard
  • Publication number: 20230131320
    Abstract: A therapeutic electrode component includes a base plate having a first side and a second side having a conductive surface. A repository having an internal volume to releasably retain a conductive fluid is disposed on the first side of the base plate. A rupturable membrane is disposed between the internal volume of the repository and the conductive surface of the base plate. A coupling is disposed on the base plate that is configured to detachably engage a gas charge, whereby the gas charge is detachable from the coupling without causing destruction of the gas charge, to provide a hermetic seal with an outlet of the gas charge, and to provide fluid communication between the internal volume of the repository and the outlet of gas charge when the gas charge is engaged by the coupling. A retainer is configured to detachably secure the gas charge to the base plate.
    Type: Application
    Filed: December 22, 2022
    Publication date: April 27, 2023
    Inventors: Scott D. Quinnell, Brian D. Snyder, Robert J. Hulings
  • Patent number: 11571561
    Abstract: A therapeutic electrode component includes a base plate having a first side and a second side having a conductive surface. A repository having an internal volume to releasably retain a conductive fluid is disposed on the first side of the base plate. A rupturable membrane is disposed between the internal volume of the repository and the conductive surface of the base plate. A coupling is disposed on the base plate that is configured to detachably engage a gas charge, whereby the gas charge is detachable from the coupling without causing destruction of the gas charge, to provide a hermetic seal with an outlet of the gas charge, and to provide fluid communication between the internal volume of the repository and the outlet of gas charge when the gas charge is engaged by the coupling. A retainer is configured to detachably secure the gas charge to the base plate.
    Type: Grant
    Filed: October 2, 2020
    Date of Patent: February 7, 2023
    Assignee: ZOLL MEDICAL CORPORATION
    Inventors: Scott D. Quinnell, Brian D. Snyder, Robert J. Hulings
  • Publication number: 20220249854
    Abstract: A modular waterproof therapeutic electrode component for preventing water ingress and for easy servicing. The component comprises a substrate comprising a conductive surface, a reservoir of conductive fluid mounted on the substrate, a reusable waterproof enclosure comprising circuitry, the reusable waterproof enclosure comprising circuitry configured to be removably coupled to the substrate, and a fluid deployment device in electrical communication with the circuitry and mounted on the substrate, the fluid deployment device configured to cause the reservoir to release the conductive fluid onto the conductive surface to reduce electrical impedance between the conductive surface and skin of a subject.
    Type: Application
    Filed: February 4, 2022
    Publication date: August 11, 2022
    Inventors: Dale Ballard, Robert J. Hulings, Scott D. Quinnell, Ronald A. Seman, Richard S. Sharbaugh, Brian D. Snyder
  • Publication number: 20220249024
    Abstract: A wearable cardiac monitoring device for providing an improved fit to a body of a patient during long term cardiac monitoring of the patient is provided. The device includes a garment configured to be worn about a torso of the patient and including a flexible material and physiological sensors configured to detect a physiological signal of the patient, the physiological sensors disposed on the flexible material and positioned at one or more anatomical locations of the patient's torso. The device also includes force applicators disposed on the flexible material proximate to the one or more physiological sensors, each of the force applicators configured to be adjustable during the long term cardiac monitoring of the patient to cause a pressure in a range of 0.05 psi to 0.65 psi to be exerted by the physiological sensors onto the one or more anatomical locations of the patient's torso.
    Type: Application
    Filed: February 3, 2022
    Publication date: August 11, 2022
    Inventors: Robert J. Hulings, Scott D. Quinnell, Philip C. Skalos, Christopher L. Swenglish, Gary A. Freeman
  • Publication number: 20220032078
    Abstract: A gel deployment device for use with an electrotherapy system is provided. The device includes a plurality of gel reservoirs disposed on a substrate, each of the plurality of gel reservoirs containing conductive gel. Each of the gel reservoirs are positioned adjacent to at least one seal such that the seal restricts flow of the conductive gel. The seal can be configured to release the conductive gel from the gel reservoir in response to pressure being applied about a perimeter of the seal at, for example, multiple points about the perimeter or substantially equally about the perimeter of the seal. In an example, each gel reservoir can be shaped such that the gel reservoir partially or fully surrounds a seal. In another example, multiple gel reservoirs can be arranged in clusters such that the multiple gel reservoirs are positioned about a single seal.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 3, 2022
    Inventors: Robert J. Hulings, Scott D. Quinnell, Dale Ballard, Ronald A. Seman
  • Patent number: 11173317
    Abstract: A gel deployment device for use with an electrotherapy system includes a substrate and a conductive surface mechanically coupled to the substrate. The device includes one or more gel reservoirs disposed on the substrate, each surrounding an open center portion, and a fluid pressure source in fluid communication with the one or more gel reservoirs. At least one frangible seal is disposed within the open center portion and configured to release a volume of conductive gel from the one or more gel reservoirs to the conductive surface.
    Type: Grant
    Filed: April 11, 2019
    Date of Patent: November 16, 2021
    Assignee: ZOLL Medical Corporation
    Inventors: Robert J Hulings, Scott D Quinnell, Dale Ballard, Ronald A. Seman
  • Publication number: 20210106811
    Abstract: A therapeutic electrode component includes a base plate having a first side and a second side having a conductive surface. A repository having an internal volume to releasably retain a conductive fluid is disposed on the first side of the base plate. A rupturable membrane is disposed between the internal volume of the repository and the conductive surface of the base plate. A coupling is disposed on the base plate that is configured to detachably engage a gas charge, whereby the gas charge is detachable from the coupling without causing destruction of the gas charge, to provide a hermetic seal with an outlet of the gas charge, and to provide fluid communication between the internal volume of the repository and the outlet of gas charge when the gas charge is engaged by the coupling. A retainer is configured to detachably secure the gas charge to the base plate.
    Type: Application
    Filed: October 2, 2020
    Publication date: April 15, 2021
    Inventors: Scott D. Quinnell, Brian D. Snyder, Robert J. Hulings
  • Publication number: 20200179693
    Abstract: A therapy electrode apparatus for dispensing conductive gel to skin of a patient wearing a wearable defibrillator includes a therapy electrode, at least one reservoir comprising the conductive gel, and a gel deployment device comprising at least two reactive chemicals. The at least one reservoir is configured to release the conductive gel between the therapy electrode and a patient's skin prior to a delivery of one or more therapeutic shocks. The gel deployment device configured to, on receiving a treatment signal from a controller of the wearable defibrillator operably connected to the gel deployment device, cause the at least two reactive chemicals to come into contact to produce a pressurized fluid to release the conductive gel from the at least one reservoir between the therapy electrode and the patient's skin.
    Type: Application
    Filed: January 2, 2020
    Publication date: June 11, 2020
    Inventors: Robert J Hulings, Scott D Quinnell, Ronald A Seman, Dale Ballard
  • Patent number: 10569090
    Abstract: Systems, devices and methods for providing a pressurized fluid for facilitating conductive gel release prior to providing cardiac therapy to a patient are disclosed. A first system can include a chemical reaction chamber including a first chemical and a second chemical isolated from each other by a mechanical barrier. The mechanical barrier is configured to be compromised upon receiving a signal from an electrotherapy device controller such that the first chemical and second chemical come into contact to produce a sufficient amount of pressurized fluid. An alternative system can include a pressure source comprising a reservoir containing a pressurized fluid. The pressure source can also include at least one release mechanism configured to cause a release of the pressurized fluid from the reservoir to an exit port of the pressure source when a wearable medical device is preparing to deliver a therapeutic shock to a patient.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: February 25, 2020
    Assignee: ZOLL Medical Corporation
    Inventors: Robert J. Hulings, Scott D. Quinnell, Ronald A. Seman, Dale Ballard
  • Publication number: 20190232071
    Abstract: A gel deployment device for use with an electrotherapy system includes a substrate and a conductive surface mechanically coupled to the substrate. The device includes one or more gel reservoirs disposed on the substrate, each surrounding an open center portion, and a fluid pressure source in fluid communication with the one or more gel reservoirs. At least one frangible seal is disposed within the open center portion and configured to release a volume of conductive gel from the one or more gel reservoirs to the conductive surface.
    Type: Application
    Filed: April 11, 2019
    Publication date: August 1, 2019
    Inventors: Robert J. Hulings, Scott D. Quinnell, Dale Ballard, Roland A. Seman
  • Patent number: 10307605
    Abstract: A gel deployment device for use with an electrotherapy system is provided. The device includes a plurality of gel reservoirs disposed on a substrate, each of the plurality of gel reservoirs containing conductive gel. Each of the gel reservoirs are positioned adjacent to at least one seal such that the seal restricts flow of the conductive gel. The seal can be configured to release the conductive gel from the gel reservoir in response to pressure being applied about a perimeter of the seal at, for example, multiple points about the perimeter or substantially equally about the perimeter of the seal. In an example, each gel reservoir can be shaped such that the gel reservoir partially or fully surrounds a seal. In another example, multiple gel reservoirs can be arranged in clusters such that the multiple gel reservoirs are positioned about a single seal.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: June 4, 2019
    Assignee: ZOLL Medical Corporation
    Inventors: Robert J Hulings, Scott D Quinnell, Dale Ballard, Ronald A Seman
  • Publication number: 20180117326
    Abstract: Systems, devices and methods for providing a pressurized fluid for facilitating conductive gel release prior to providing cardiac therapy to a patient are disclosed. A first system can include a chemical reaction chamber including a first chemical and a second chemical isolated from each other by a mechanical barrier. The mechanical barrier is configured to be compromised upon receiving a signal from an electrotherapy device controller such that the first chemical and second chemical come into contact to produce a sufficient amount of pressurized fluid. An alternative system can include a pressure source comprising a reservoir containing a pressurized fluid. The pressure source can also include at least one release mechanism configured to cause a release of the pressurized fluid from the reservoir to an exit port of the pressure source when a wearable medical device is preparing to deliver a therapeutic shock to a patient.
    Type: Application
    Filed: October 27, 2017
    Publication date: May 3, 2018
    Applicant: ZOLL Medical Corporation
    Inventors: Robert J. HULINGS, Scott D. QUINNELL, Ronald A. SEMAN, Dale BALLARD
  • Publication number: 20180001101
    Abstract: A gel deployment device for use with an electrotherapy system is provided. The device includes a plurality of gel reservoirs disposed on a substrate, each of the plurality of gel reservoirs containing conductive gel. Each of the gel reservoirs are positioned adjacent to at least one seal such that the seal restricts flow of the conductive gel. The seal can be configured to release the conductive gel from the gel reservoir in response to pressure being applied about a perimeter of the seal at, for example, multiple points about the perimeter or substantially equally about the perimeter of the seal. In an example, each gel reservoir can be shaped such that the gel reservoir partially or fully surrounds a seal. In another example, multiple gel reservoirs can be arranged in clusters such that the multiple gel reservoirs are positioned about a single seal.
    Type: Application
    Filed: June 29, 2016
    Publication date: January 4, 2018
    Inventors: Robert J. Hulings, Scott D. Quinnell, Dale Ballard, Ronald A. Seman
  • Patent number: 6253099
    Abstract: An ECG electrode and method of making and using such. The electrode can have a domed electrode element attached to a housing containing an interface disk to which the concave side of the domed electrode connects. Within the housing a signal lead wire has one end attached to the non-skin-contacting side of the dome and another end connected to a signal transition circuit and a buffer amplifier circuit. The domed electrode element can be made by forming a metal disk into a dome and providing an oxide layer over the convex surface of the dome. The convex surface of the domed electrode can ensure reliable ECG signal acquisitions with lower radial forces generally than other electrode types, when positioned adjacent the skin of the patient and when coupled to cardiac activity monitoring equipment and a defibrillator for cardiac sensing capabilities.
    Type: Grant
    Filed: August 19, 1999
    Date of Patent: June 26, 2001
    Assignee: Lifecor, Inc.
    Inventors: Emil Oskin, Robert J. Hulings, Scott D. Quinnell